Gaeckler A, Al-Dakkak I, Saval N, Dieperink HH, et al. Effectiveness and Safety of Switching to Ravulizumab From Eculizumab in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome: A Global aHUS Registry Analysis. Clin Transplant 2025;39:e70278.
PMID: 40875209